News

Some experts believe that unlike in the Olympics, silver’s ability to kill bacteria and keep wounds from getting infected is second to none. Many of the antimicrobial dressings used today have such high concentrations of silver, though, that they can cause irritation and even be toxic to healthy human skin cells. Thus, “clinical guidelines recommend […]

Hudson, WI – August 17, 2016 – Phillips-Medisize Corporation (Phillips-Medisize), a global leader in outsource design, development and manufacturing services for the medical industry announced today that it has entered into a binding agreement to be acquired by Molex LLC (Molex), a global manufacturer of complete interconnect solutions. Phillips-Medisize is a portfolio company of San […]

For Immediate Release August 17, 2016 Winners Announced for 2016 Wisconsin Innovation Awards Ten Winners Announced at Madison Awards Ceremony Milwaukee— August 17, 2016 — Ten winners have been announced from the thirtyfive finalists and more than 180 nominees for the 2016 Wisconsin Innovation Awards. At an awards ceremony emceed by Jeanan Yasiri Moe and […]

Zurex Pharma, which is developing antimicrobial products for healthcare-associated infections, has raised more than $6.2 million in equity funding, according to a regulatory filing that was made public on Thursday. In a press release, Middleton, WI-based Zurex said the money is an “initial close of a Series C financing,” and will be used in part […]

CHESTERFIELD, United Kingdom, Aug. 10, 2016 /PRNewswire/ — Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced that it has entered into a merger agreement with Stratatech Corporation, a privately held regenerative medicine company focused on the development of unique, proprietary skin substitute products. Developmental products include StrataGraft regenerative skin tissue and a technology […]

July 27, 2016 09:17 AM Eastern Daylight Time MADISON, Wis.–(BUSINESS WIRE)–FluGen Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of more effective influenza vaccines, today announced the initiation of the first Phase 1 clinical trial of its RedeeFlu™ universal influenza vaccine. The trial is a randomized, blinded, dose-ranging Phase 1 study of […]

By ANDREW ZALESKI, originally published in MedCity News   In the healthcare industry, be attentive to where medicine and technology intersect—where people from the clinical and pharmaceutical worlds rub elbows with computer scientists and programmers. That’s where Shelley Zhuang, founder of investment firm Eleven Two Capital, said her company looks to invest during one of […]

A few nights ago, I had the pleasure of attending my first BioForward networking and lecture event. Sponsored by and hosted at Quarles & Brady in downtown Milwaukee, the event focused around the topic of the microbiome, a field that has been gaining more and more attention over the past few years. The folks at BioForward […]